Website intended for a NZ health professional readership
Ranche Johnson (Ngāpuhi), a specialist GP with over 20 years’ experience, is the National Hauora Coalition’s new clinical director after the departure to Te Aka Whai Ora – Māori Health Authority of Rawiri McKree Jansen. Dr Johnson practises at Tiakina Te Ora in Papakura and has worked in practices in Ōtara, Manukau and Manurewa Marae. She is an RNZCGP fellowship assessor, medical educator and hauora Māori facilitator. She says she is passionate about health equity and enabling quality care in general practice to meet the needs of communities and deliver more equitable health outcomes, particularly for Māori.
Te Aka Whai Ora has appointed Merewaakana Kingi (Ngāti Awa, Ngāitai) its chief executive – finance and support services. Ms Kingi joined Te Aka Whai Ora earlier this month from Ngāti Awa Group Holdings Ltd, where she was group chief financial officer (commercial and iwi). Earlier, she worked for the likes of Deloitte, Morgan Stanley and Air New Zealand. A former New Zealand Black Fern and touch player, she says she looks forward to leading positive change for Māori.
Specialist GP Stephan Lombard is the new chair of the RNZCGP’s National Advisory Council. Dr Lombard, owner of Cook Street Health Centre in Palmerston North, has more than 30 years’ GP experience. As chair, he becomes an ex-officio member of the college board. The council is made up of a member from each chapter, faculty and Te Akoranga a Māui. Meetings are held quarterly to kōrero local and national member issues, with significant concerns taken to the board for consideration. – Abridged, with permission, from ePulse
We're publishing this article as a FREE READ so it is FREE to read and EASY to share more widely. Please support us and the hard work of our journalists by clicking here and subscribing to our publication and website
Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
